Dna X (SONM) Operating Margin (2018 - 2025)
Historic Operating Margin for Dna X (SONM) over the last 8 years, with Q3 2025 value amounting to 24.55%.
- Dna X's Operating Margin fell 87300.0% to 24.55% in Q3 2025 from the same period last year, while for Sep 2025 it was 54.43%, marking a year-over-year decrease of 318900.0%. This contributed to the annual value of 57.7% for FY2024, which is 582500.0% down from last year.
- Dna X's Operating Margin amounted to 24.55% in Q3 2025, which was down 87300.0% from 60.16% recorded in Q2 2025.
- In the past 5 years, Dna X's Operating Margin registered a high of 3.86% during Q1 2025, and its lowest value of 147.52% during Q4 2024.
- Its 5-year average for Operating Margin is 36.73%, with a median of 24.55% in 2025.
- In the last 5 years, Dna X's Operating Margin surged by 693100bps in 2022 and then tumbled by -1381700bps in 2024.
- Quarter analysis of 5 years shows Dna X's Operating Margin stood at 73.71% in 2021, then soared by 94bps to 4.39% in 2022, then tumbled by -113bps to 9.34% in 2023, then crashed by -1479bps to 147.52% in 2024, then soared by 83bps to 24.55% in 2025.
- Its Operating Margin stands at 24.55% for Q3 2025, versus 60.16% for Q2 2025 and 3.86% for Q1 2025.